Erlotinib Hydrochloride

Product NDC
42292-053
11-digit product format
422920053
Labeler code
42292
Product ID
42292-053_b4dc994e-d507-2fc0-e053-2a95a90ae131
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
erlotinib hydrochloride
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Mylan Institutional Inc.
Application
ANDA091002
Marketing category
ANDA
Marketing start
2019-05-28
Marketing end
2021-01-31
Substance
ERLOTINIB
Active strength
150 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
42292-053-01EA - Each42292-053df203450-6cd6-4b11-8f52-e5c75945d1b312019-06-19
42292-053-05EA - Each42292-053eaa8f2d5-86d2-4812-8857-ce8fc85bff8412019-06-19